Showing results (31-40 of 55) with videos related to
Sort By:
Pageof 6
The Australasian Journal of Dermatology|May 22, 2024
Cross-sectional burden-of-illness study in atopic dermatitis (MEASURE-AD) in Australia and New Zealand reveals impacts on well-beingMarius Rademaker, Paul Jarrett, Dedee F Murrell, et al.Dermatology and Therapy|January 1, 2023
Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled StudyStephen K Tyring, Phoebe Rich, Yayoi Tada, et al.Archives of Dermatology|September 13, 2002
Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimensStephen Shumack, June Robinson, Steven Kossard, et al.Clinical and Experimental Dermatology|February 12, 2022
Method of Assessing Skin Cancerization and KeratosesTM (MASCK™): development and photographic validation in multiple anatomical sites of a novel assessment tool intended for clinical evaluation of patients with extensive skin field cancerizationChristopher Baker, Amelia James, Madeleine Supranowicz, et al.The Australasian Journal of Dermatology|May 5, 2020
Practice guidelines for teledermatology in AustraliaLisa M Abbott, Robert Miller, Monika Janda, et al.The Australasian Journal of Dermatology|September 20, 2022
Dupilumab-associated ocular surface disease: An interdisciplinary decision framework for prescribers in the Australian settingPeter Foley, Yves A Kerdraon, John P Hogden, et al.The Australasian Journal of Dermatology|June 3, 2015
Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in AustraliaJo-Ann See, Stephen Shumack, Dedee F Murrell, et al.The Journal of Dermatological Treatment|May 23, 2022
Preliminary efficacy and safety analysis: 12-month results in 83 patients using a novel approach of widefield radiation therapy for extensive skin field cancerization with or without keratinocyte cancersAndrew E Potter, Christopher Baker, Stephen Shumack, et al.The Australasian Journal of Dermatology|April 2, 2020
A review of literature supporting the development of practice guidelines for teledermatology in AustraliaLisa M Abbott, Robert Miller, Monika Janda, et al.Journal of the American Academy of Dermatology|April 19, 2022
Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND)Vivian Y Shi, Tina Bhutani, Luz Fonacier, et al.Pageof 6